Case of the month #180: Atypical thalamic and mesencephalic neurocytoma--a rare neoplasm in children.

Can Assoc Radiol J

Department of Diagnostic Imaging, Hamilton General Hospital, Hamilton Health Science, McMaster University, Hamilton, Ontario, Canada.

Published: February 2013

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carj.2010.09.006DOI Listing

Publication Analysis

Top Keywords

case month
4
month #180
4
#180 atypical
4
atypical thalamic
4
thalamic mesencephalic
4
mesencephalic neurocytoma--a
4
neurocytoma--a rare
4
rare neoplasm
4
neoplasm children
4
case
1

Similar Publications

Background: Low-grade fibromyxoid sarcoma is a rare soft tissue tumor characterized by a benign histological appearance but with a high potential for recurrence and metastasis. First described by Evans in 1987, recurrence and metastasis can occur decades after the initial diagnosis, complicating long-term management.

Case Presentation: We report the case of an 83-year-old Jewish female patient diagnosed with low-grade fibromyxoid sarcoma in her right shoulder.

View Article and Find Full Text PDF

Background: Lip behaviors can lead to maxillofacial developmental disorders such as anterior open bite, posterior crossbite, increased overjet, and a higher risk of developing a Class II malocclusion. However, lip-sucking, a behavior often underreported and overlooked, may adversely affect the periodontal health of permanent teeth in adolescents under extreme conditions if not promptly identified and managed.

Case Presentation: We report a unique case of an 11-year-old boy with a severe periodontal-endodontic lesion on tooth 32, caused by prolonged, high-frequency, and high-intensity lip sucking.

View Article and Find Full Text PDF

NLRP3 is a BMI-independent mediator of stable COPD.

BMC Pulm Med

January 2025

İzmir International Biomedicine and Genome Institute, Dokuz Eylül University, İzmir, Türkiye.

Purpose: The inflammatory response in animal models of chronic obstructive pulmonary disease (COPD) is activated by the NLR-family-pyrin-domain-containing-3 (NLRP3) inflammasome pathway, which is also known to play a role in obesity-related inflammation. The NLRP3/caspase-1/interleukin (IL)-1β pathway might be involved in the progression of COPD with increasing body mass index. To our knowledge, no previous studies have explored the role of NLRP3 inflammasome markers in linking COPD and obesity.

View Article and Find Full Text PDF

Background: The impact of Prader-Willi syndrome (PWS) domain gene expression on the growth of healthy children is not well understood. This study investigated associations between PWS domain gene expression in umbilical cord tissue and prenatal and postnatal growth, considering potential sex differences.

Methods: Relative gene expression of paternally expressed MAGEL2, NDN, and SNURF-SNRPN, and the small nucleolar RNAs SNORD116 and SNORD115 were determined by real-time quantitative polymerase chain reaction in umbilical cord tissue from 122 healthy newborns (59 girls and 63 boys).

View Article and Find Full Text PDF

Simultaneous Treatment of Pseudo-gynecomastia and Lateral Chest in Patients with Massive Weight Loss.

Aesthetic Plast Surg

January 2025

Department of Plastic, Burn and Maxillofacial Surgery, Ain Shams University, 7 Mohsen Roshdy street, Nasr City, Cairo, 11731, Egypt.

Background: Pseudogynecomastia in MWL patients is characterized by excess skin in chest, lateral chest, axilla and upper abdomen without enlargement of the breast glandular component. The aim of this work was to study long-term aesthetic outcomes of correction of severe pseudogynecomastia post-weight loss with inferior pedicle technique with some refinements.

Methodology: This prospective study included 15 patients underwent chest contouring after massive weight loss within period of 2 years between January 2022 and January 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!